You are here

Article Text

Article menu
Download PDFPDF
Summary
Chairmen’s summary
  1. E BRAUNWALD
  1. Brigham and Women’s Hospital and Harvard Medical School
  2. Boston, Massachusetts, USA
  3. Fundación Favaloro, Av Belgrano 1746
  4. Buenos Aires, Argentina
    1. E GURFINKEL
    1. Brigham and Women’s Hospital and Harvard Medical School
    2. Boston, Massachusetts, USA
    3. Fundación Favaloro, Av Belgrano 1746
    4. Buenos Aires, Argentina

      https://doi.org/10.1136/hrt.82.2008.i21

      Statistics from Altmetric.com

        Request Permissions

        If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

        The papers presented here have indicated that low molecular weight heparins are efficacious and cost effective in the treatment of unstable angina and non-Q wave myocardial infarction. Amendments to the classification, ongoing risk assessment, and duration and appropriate treatment are all areas of the management of these conditions which were highlighted in this symposium as needing further research.

        Classification

        The classification of unstable angina based on clinical description remains valid. It is likely that further refinements and expansions to the classification will be made in the future, on the basis of the balance of five separate causal factors (thrombosis, …

        View Full Text